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Loss of muscle mass and function is a common occurrence in liver transplant Familial
Amyloidotic Polyneuropathy (FAP) patients. Sarcopenia is associated with morbidity
and mortality before and after liver transplantation. However, the ability of skeletal
muscle mass to recover after transplant remains uncertain, and so as the the importance
of clinical exercise prescription.
Participants were 39 FAP patients (22 males) aged 23-59 years, who had been
submitted to a liver transplant (Tx) 2-4 months earlier. Sarcopenia was defined
according to the criteria of the International Working Group on Sarcopenia and Society
of Sarcopenia, Cachexia and Wasting Disorders1.
Whole-body dual X-ray absorptiometry (DXA) was used to measure body fat and lean-
soft tissue.
From this data, appendicular skeletal muscle mass (kg) was calculated by summing the
muscle mass of the four limbs, assuming that all non-fat and non-bone mass is skeletal
muscle. Skeletal Muscle Index (SMI) was calculated adjusting appendicular skeletal
muscle mass to the squared height.
Functional aerobic capacity was assessed using the 6 min walk test (6MWT) and
handgrip strength was measured on the dominant hand using a hand dynamometer.
The prevalence of sarcopenia according to SMI values was 45,5% in males and
41,2% in females. According Dunn (2017)3 diminished SMI is strongly associated
with increased hospitalizations and cost of care
In addition, 27,3% of males and 17,6% of the females could be classified as having
sarcopenia with low mobility (distance < 400m).
Sarcopenia seems to have a high prevalence in liver transplanted patients and could
be also prevalent in FAP patients due to essentially previous malnutrition problems
associated to this disease. Liver transplant seems to increase its prevalence, probably
because of the aggressive medication with impact on muscle metabolism. However
the association between sarcopenia in FAP patients with or without liver transplant
was not studied yet. Future studies should examine the efficacy of non-
pharmacological, multimodal approaches, such as exercise training and a nutritional
intervention, that may substantially reduce the functional decline in TX FAP.
Table 1 – Characterization of sample  (22 males; 17 females)
Fig. 2 – SMI distribution in males  Fig. 3 – SMI distribution in females
A fat mass higher than 16% for males and 26% for females was found in 54,5% of
males and 52,9% of females.
Values for low handgrip strength related with sarcopenia definition were found in
27,3% of males (handgrip<30kg) and in 17,6% of females (handgrip < 20kg).
Fig. 3 –6MWT distribution by gender. 
Fig. 1 - Associations between handgrip strength and SMI
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VARIABLE Males (22) Females (17)
Age (years) 31.7±7.9 37.1±5.0
Time Post-Tx (month) 4.1±1.9 3.4±1.9
Weight (Kg) 67.7±13.2 56.8±10.6
Height (m) 1.7±0.1 1.6±0.1
BMI 22.4±4.0 21.6±3.9
Fat Mass (%) 18.7±7.4 27.8±7.6
Total Skeletal Muscle Mass 
(TSMM)(kg) 25.5±4.3 17.2±2.4
Skeletal Muscle Index (SMI) 7.2±1.0 5.7±0.8
Right Handgrip 37.4±11.8 27.7±7.9
6MWT (m) 507.7±150.4 514.3±121.4
Legend: BMI - Body Mass Index; TSMM acording equation of Kim, Wang et al, 2002 2 ; SMI = 
Appendicular Skeletal Mass adjusted to squared height in meters; 6MWT - 6 minutes walk test 
Also for this population a strong association was verified between handgrip strength
and SMI.
